PMC:7113610 / 20171-20314 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"705","span":{"begin":104,"end":114},"obj":"Species"},{"id":"723","span":{"begin":64,"end":71},"obj":"Disease"},{"id":"724","span":{"begin":76,"end":95},"obj":"Disease"}],"attributes":[{"id":"A705","pred":"tao:has_database_id","subj":"705","obj":"Tax:2697049"},{"id":"A723","pred":"tao:has_database_id","subj":"723","obj":"MESH:D004342"},{"id":"A724","pred":"tao:has_database_id","subj":"724","obj":"MESH:D003141"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The mRNA based vaccine prepared by the US National Institute of Allergy and Infectious Diseases against SARS-CoV-2 is under phase 1 trial [72]."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T83","span":{"begin":4,"end":8},"obj":"Body_part"}],"attributes":[{"id":"A83","pred":"fma_id","subj":"T83","obj":"http://purl.org/sig/ont/fma/fma67122"}],"text":"The mRNA based vaccine prepared by the US National Institute of Allergy and Infectious Diseases against SARS-CoV-2 is under phase 1 trial [72]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T217","span":{"begin":64,"end":71},"obj":"Disease"},{"id":"T218","span":{"begin":76,"end":86},"obj":"Disease"},{"id":"T219","span":{"begin":104,"end":112},"obj":"Disease"},{"id":"T220","span":{"begin":104,"end":108},"obj":"Disease"}],"attributes":[{"id":"A217","pred":"mondo_id","subj":"T217","obj":"http://purl.obolibrary.org/obo/MONDO_0005271"},{"id":"A218","pred":"mondo_id","subj":"T218","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A219","pred":"mondo_id","subj":"T219","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A220","pred":"mondo_id","subj":"T220","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"The mRNA based vaccine prepared by the US National Institute of Allergy and Infectious Diseases against SARS-CoV-2 is under phase 1 trial [72]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T148","span":{"begin":0,"end":143},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The mRNA based vaccine prepared by the US National Institute of Allergy and Infectious Diseases against SARS-CoV-2 is under phase 1 trial [72]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T26","span":{"begin":64,"end":71},"obj":"Phenotype"}],"attributes":[{"id":"A26","pred":"hp_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/HP_0012393"}],"text":"The mRNA based vaccine prepared by the US National Institute of Allergy and Infectious Diseases against SARS-CoV-2 is under phase 1 trial [72]."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T595","span":{"begin":104,"end":114},"obj":"SP_7"},{"id":"T31454","span":{"begin":104,"end":114},"obj":"SP_7"}],"text":"The mRNA based vaccine prepared by the US National Institute of Allergy and Infectious Diseases against SARS-CoV-2 is under phase 1 trial [72]."}